Glycohaemoglobin measurement: methodological differences in relation to interference by urea

被引:11
作者
Lee, KF
Szeto, YT
Benzie, IFF
机构
[1] Hong Kong Polytech Univ, Dept Nursing & Hlth Sci, Kowloon, Hong Kong, Peoples R China
[2] Caritas Med Ctr, Clin Pathol Unit, Kowloon, Hong Kong, Peoples R China
关键词
glycohaemoglobin; cation exchange HPLC; boronate affinity method; urea; carbamylated haemoglobin; diabetes;
D O I
10.1007/s005920200010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to investigate the agreement between a ration-exchange HPLC method and a boronate affinity method of measuring glycohaemoglobin (HbA(1c)), with particular reference to the effect of elevated urea concentration. HbA(1c)was measured by both methods in samples from 75 subjects who were classified as diabetic with normal (n=36) or abnormal (n=12) renal function, and non-diabetic with normal (n=8) or abnormal (n=19) renal function. Urea was found to cause a clinically significant interference in the HPLC method at a level greater than or equal to17.0 mmol/l. Each increase of 1 mmol/l urea in serum was associated with an absolute increase of 0.04% in the HbA(1c) value as measured by the HPLC method. The boronate affinity method for HbA(1c) did not appear to be affected by elevated urea concentration. There was significant correlation (r=0.97, p<0.001) between HbA(1c) results obtained by the two methods, however, results obtained by the boronate affinity method were generally lower. The discrepancy between results obtained by the two methods was particularly marked in uraemic samples from diabetic subjects, as the HPLC/boronate affinity difference increased as the HbA(1c) increased and also as the urea concentration increased. Results indicate that blood from diabetic patients with renal failure may give erroneously high HbA(1c) values by HPLC. Results also highlight the importance of choosing appropriate clinical samples and statistical techniques when evaluating or comparing test methods.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 12 条
[1]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[2]  
BLAND JM, 1998, JHONG KONG HOSP AUTH
[3]   Influence of in vivo hemoglobin carbamylation on HbA1c measurements by various methods [J].
Chachou, A ;
Randoux, C ;
Millart, H ;
Chanard, J ;
Gillery, P .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (04) :321-326
[4]  
ENGBAEK F, 1989, CLIN CHEM, V35, P93
[5]  
GOLDSTEIN DE, 1994, CLIN CHEM, V40, P1637
[6]   The narrow therapeutic window of glycated hemoglobin and assay variability [J].
Hosseini, SS ;
Bibler, I ;
Charles, MA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (12) :1498-1502
[7]   TOWARD A BASIC UNDERSTANDING OF DIABETIC COMPLICATIONS [J].
STEFFES, MW ;
MAUER, SM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (12) :883-884
[8]  
VRY L, 2001, CLIN CHEM, V42, P153
[9]  
Weykamp CW, 1999, CLIN CHEM, V45, P438
[10]  
WEYKAMP CW, 1993, CLIN CHEM, V39, P138